Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Family man survives thanks to CARL.

Sudden cardiac death can strike anyone. Only about ten percent of patients resuscitated outside a hospital survive cardiac arrest. And after resuscitation, a high percentage of survivors suffer from persistent serious neurological sequelae, particularly affecting brain function. CARL Technology has been developed to help more people survive cardiac arrest and improve the neurological recovery. Worldwide in any location. In- and out-of-hospital as well.

Jörg Teichfischer

Jörg Teichfischer suffered a cardiac arrest at home in spring 2023. He was resuscitated by an emergency physician by means of defibrillator and cardiac massage for 55 minutes. Afterwards an ambulance took him to the Ortenau Klinikum Lahr, where resuscitative measures continued for almost 20 minutes. However, it was only through the application of CARL Therapy that the heart of the 48-year-old family man started to beat again by its own and in the right rhythm.

CARL Therapy bought the physicians time to treat the patient. They placed a stent in his heart to keep the vessels open. In rehab, Jörg Teichfischer recovered from his cardiac arrest. He did not retain any organic or neurological sequelae. “I am infinitely grateful for receiving CARL and that I am therefore still alive”, says Jörg Teichfischer in retrospect.

Jörg Teichfischer’s story has been told in a feature by RTL:

Hoffnung für Herzinfarkt-Patienten: Maschine CARL kann Leben retten (rtl.de)

Photos: RTL.de

Close